Hawk Ridge Capital Management’s Globus Medical GMED Stock Holding History

Hawk Ridge Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-499,980	Closed	-$43.1M	–	50
2026 Q1	$43.1M	Buy	+499,980	New	+$44.9M	1.57%	24
2025 Q4	–	Sell	-1,569,235	Closed	-$89.9M	–	41
2025 Q3	$89.9M	Sell	1,569,235 -553,976	-26%	-$31.9M	4.28%	10
2025 Q2	$125M	Buy	2,123,211 +443,136	+26%	+$28.6M	5.23%	1
2025 Q1	$123M	Buy	1,680,075 +4,564	+0.3%	+$377K	5.81%	1
2024 Q4	$139M	Sell	1,675,511 -501,906	-23%	-$39.6M	6.59%	1
2024 Q3	$156M	Sell	2,177,417 -192,360	-8%	-$13.6M	6.72%	1
2024 Q2	$162M	Buy	2,369,777 +2,936	+0.1%	+$175K	6.98%	1
2024 Q1	$127M	Buy	+2,366,841	New	+$127M	5.72%	1
2023 Q4	–	Sell	-2,225,772	Closed	-$111M	–	46
2023 Q3	$111M	Buy	2,225,772 +537,972	+32%	+$30.1M	5.44%	1
2023 Q2	$100M	Buy	1,687,800 +92,000	+6%	+$5.24M	5.33%	3
2023 Q1	$90.4M	Buy	+1,595,800	New	+$102M	5.13%	4

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Hawk Ridge Capital Management's GMED Position: Q2 2026 in Review

Hawk Ridge Capital Management sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 499,980 shares — an estimated $43.1M sold.

Hawk Ridge Capital Management first reported a position in GMED in Q1 2023 and held it in 11 quarters. The position peaked at $162M in Q2 2024. 594 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Hawk Ridge Capital Management reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
Hawk Ridge Capital Management sold 499,980 Globus Medical shares in Q2 2026, an estimated $43.1M.
Hawk Ridge Capital Management first reported a position in Globus Medical in Q1 2023 and held it in 11 quarters.
Hawk Ridge Capital Management's Globus Medical position peaked at $162M in Q2 2024.
594 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Hawk Ridge Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.